HLA-DRB1 anticorps
HLA-DRB1
Reactivité: Humain
WB, IF, IC
Hôte: Lapin
Polyclonal
unconjugated
N° du produit ABIN7307126
-
-
Antigène
Voir toutes HLA-DRB1 Anticorps
-
HLA-DRB1
(Major Histocompatibility Complex, Class II, DR beta 1 (HLA-DRB1))
-
Reactivité
-
Humain
-
Hôte
-
Lapin
-
Clonalité
-
Polyclonal
-
Conjugué
-
Cet anticorp HLA-DRB1 est non-conjugé
-
Application
-
Western Blotting (WB), Immunofluorescence (IF), Immunochromatography (IC)
-
Specificité
-
Recognizes endogenous levels of HLA-DRB1 protein.
-
Attributs du produit
-
Rabbit polyclonal antibody to HLA-DRB1
-
Purification
-
The antibody was purified by immunogen affinity chromatography.
-
Immunogène
-
Recombinant full length protein of human HLA-DRB1
-
Top Product
-
Discover our top product HLA-DRB1 Anticorps primaire
-
-
-
Indications d'application
-
WB (1:500 - 1:2000), IF/IC (1:50 - 1:100)
-
Restrictions
-
For Research Use only
-
-
Format
-
Liquid
-
Buffer
-
Liquid in 0.42 % Potassium phosphate, 0.87 % Sodium chloride, pH 7.3, 30 % glycerol, and 0.01 % sodium azide.
-
Agent conservateur
-
Sodium azide
-
Précaution d'utilisation
-
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
-
-20 °C
-
Stockage commentaire
-
Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
-
Date de péremption
-
12 months
-
-
Antigène
-
HLA-DRB1
(Major Histocompatibility Complex, Class II, DR beta 1 (HLA-DRB1))
-
Autre désignation
-
HLA-DRB1 (HLA-DRB1 Produits)
-
Synonymes
-
anticorps MGC108235, anticorps DRB1, anticorps DRw10, anticorps HLA-DR1B, anticorps HLA-DRB, anticorps SS1, anticorps major histocompatibility complex, class II, DR beta 1, anticorps hla-drb1, anticorps HLA-DRB1
-
Sujet
-
HLA class II histocompatibility antigen, DRB1-3 chain, Clone P2-beta-3, MHC class II antigen DRB1*3
-
ID gène
-
3123
-
UniProt
-
P01912
-
Pathways
-
TCR Signaling, Positive Regulation of Peptide Hormone Secretion, Production of Molecular Mediator of Immune Response, CXCR4-mediated Signaling Events, Cancer Immune Checkpoints
-